Today, Cosmo Pharmaceuticals N.V. launches a public exchange offer under Swiss takeover rules to fully acquire and delist Cassiopea S.p.A. The exchange ratio follows current market prices.
Further information is available on https://www.cosmopharma.com/news-andreleases/2021/211004 and on https://www.cassiopea.com/web-filter/